Complement component C5 iRNA compositions and methods of use thereof
US-12590305-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Foster Donald patents
Foster Donald is listed as an inventor on 52 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Foster Donald |
| Total patents | 52 |
| First publication | Sep 3, 2015 |
| Latest publication | Mar 31, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
US-12584130-B2 · Mar 24, 2026 · US
Reversir molecules and methods of use thereof
US-2026055413-A1 · Feb 26, 2026 · US
Compositions and methods for silencing UGT1a1 gene expression
US-12503699-B2 · Dec 23, 2025 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025064943-A1 · Feb 27, 2025 · US
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025043279-A1 · Feb 6, 2025 · US
COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2024271136-A1 · Aug 15, 2024 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2024191236-A1 · Jun 13, 2024 · US
Complement component C5 iRNA compositions and methods of use thereof
US-11873491-B2 · Jan 16, 2024 · US
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
US-11834661-B2 · Dec 5, 2023 · US
Recent patents
Latest publications not already listed above.
SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023365965-A1 · Nov 16, 2023 · US
RNAi COMPOSITIONS AND METHODS OF USE THEREOF FOR DELIVERY BY INHALATION
US-2023287424-A1 · Sep 14, 2023 · US
Serpina1 iRNA compositions and methods of use thereof
US-11725207-B2 · Aug 15, 2023 · US
TMPRSS6 iRNA compositions and methods of use thereof
US-11725209-B2 · Aug 15, 2023 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023123192-A1 · Apr 20, 2023 · US
Methods and compositions for treating an angiotensinogen- (agt-) associated disorder
US-2023002765-A1 · Jan 5, 2023 · US
Compositions and methods for silencing ugt1a1 gene expression
US-2022389429-A1 · Dec 8, 2022 · US
Modified RNA agents with reduced off-target effect
US-11504391-B1 · Nov 22, 2022 · US
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
US-11419942-B2 · Aug 23, 2022 · US
COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2022090068-A1 · Mar 24, 2022 · US
Modified double stranded oligonucleotide
US-2021388356-A1 · Dec 16, 2021 · US
Complement component C5 iRNA compositions and methods of use thereof
US-11162098-B2 · Nov 2, 2021 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021310006-A1 · Oct 7, 2021 · US
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021269796-A1 · Sep 2, 2021 · US
SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021254063-A1 · Aug 19, 2021 · US
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021163952-A1 · Jun 3, 2021 · US
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
US-11015201-B2 · May 25, 2021 · US
Serpina1 iRNA compositions and methods of use thereof
US-10995336-B2 · May 4, 2021 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021095290-A1 · Apr 1, 2021 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021046187-A1 · Feb 18, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Alnylam Pharmaceuticals Inc | 49 |
| Genzyme Corp | 3 |
| Alnylam Pharmaceuticals | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/14 | 52 |
| C12N2310/351 | 48 |
| C12N2310/315 | 45 |
| C12N15/113 | 44 |
| A61K31/713 | 43 |